StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CTOR

Citius Oncology, Inc.

CTOR Nasdaq Pharmaceutical Preparations EDGAR ↗
$0.63
+0.05 +8.95%

Key statistics

from XBRL data in SEC filings
Market cap
$58.2M
Revenue (TTM)
Net income (TTM)
-$42.5M
EPS (TTM)
$-0.47
P/E ratio
Dividend yield
Free cash flow
Cash
$2.63M
Total assets
$101M
Gross margin
52-week range
$0.49 – $2.25

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jun 1, 2026 8-K Results of operations (earnings release) May 15, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events May 6, 2026 8-K Other events Apr 29, 2026 8-K Delisting notice or listing-rule failure Apr 28, 2026 8-K Other events Mar 31, 2026 8-K Other events Mar 10, 2026 8-K Other events Mar 4, 2026 8-K Results of operations (earnings release) Feb 13, 2026 10-Q Quarter ended 2025-12-31 Feb 13, 2026 8-K Results of operations (earnings release) Dec 23, 2025 10-K Fiscal year ended 2025-09-30 Dec 23, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Dec 10, 2025 8-K Regulation FD disclosure; Other events Dec 1, 2025 8-K Director or officer change; Shareholder vote results Oct 27, 2025 8-K Regulation FD disclosure Oct 23, 2025 8-K Unregistered sale of equity; Director or officer change Sep 19, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Sep 10, 2025 8-K Other events Aug 18, 2025 8-K Results of operations (earnings release) Aug 12, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Entered a material agreement; Other events Jul 18, 2025 8-K Other events Jun 27, 2025 8-K Other events Jun 17, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Delisting notice or listing-rule failure Apr 25, 2025 8-K Entered a material agreement Apr 3, 2025 8-K Other events Feb 14, 2025 10-Q Quarter ended 2024-12-31 Feb 14, 2025 8-K Other events Feb 6, 2025 10-K/A Fiscal year ended 2024-09-30 Jan 27, 2025 8-K Other events Jan 7, 2025 8-K Other events Jan 6, 2025 8-K Results of operations (earnings release) Dec 27, 2024 10-K Fiscal year ended 2024-09-30 Dec 27, 2024 8-K Other events Nov 12, 2024 8-K Entered a material agreement Sep 13, 2024 8-K Other events Sep 5, 2024